Breaking News on Supplements & Nutrition - EuropeUS edition

On your radar > Financial plays

Financial plays

Digging below the bottom lines of ingredients suppliers and brand behemoths. From the impact of the ongoing economic slowdown to the latest in merger and acquisition activity.

Barentz bolsters UK presence with life-sciences acquisition

€650m Dutch supplier Barentz Europe has built on its ever-expanding European and global presence by acquiring UK life sciences firm, Forum Products Ltd for an undisclosed sum.

Unilever to shed food side...? CSM to be split up..? Speculation continues

2012 set to see some heavyweight M&A activity? Definitely, say leading food market analysts

Is there appetite for M&A activity in 2012? Food market watchers reckon the sector could see some heavyweight deals next year despite the on-going credit lending challenges.

Dispatches from FiE

Solbar glad new owners can not only count soy beans, but grow them

Israeli soy player Solbar was acquired by the US farmers co-op, CHS last month, an acquisition the company welcomes for more than just financial reasons after some difficult years.

CHS to acquire Israeli soy protein company Solbar for $133m

The United States’ biggest farmer-owned cooperative CHS Inc. has signed an agreement to acquire soy protein company Solbar for $133m, sending share prices in the Israeli company soaring.

John Moloney, Group MD Glanbia

Despite ‘headwinds’ Glanbia could hit acquisition trail again in 2012, analyst

Irish dairy ingredients and cheese manufacturer Glanbia could be on the look-out for acquisitions again in 2012, according to an analyst based in the country.

H1 revenues jumped 15% to €636m for Chr Hansen. EBIT is expected to be above 26%

Chr. Hansen claims 'solid performance' allows hike in R&D investments

Chr. Hansen’s full-year results are in line with expectations, says an analyst, but positives noted were the suppliers’ expectations for its EBIT margin growth and the better performance for its...

Swedish authorities approve Arla's merger with struggling Milko

The Swedish Competition Authority (Konkurrensverket) has approved Arla’s merger with struggling Swedish dairy processor Milko, which had faced bankruptcy in the event of the deal not going through.

Indena buys into Thorne as it targets US supplements-pharma niche

Italian botanical extracts giant Indena has gained an undisclosed shareholding in US supplements manufacturer, Thorne Research, that will see the two working to expand their presence in areas like cancer...

Naturex targets acquisitions as profits rise

French botanicals supplier has seen profits rise 28% to €9.7m in the first half of 2011 compared to H1 2010, and says its policy of seeking acquisitions remains unchanged.

Dairy prices to soften, says Glanbia

A modest weakening in dairy prices is expected, forecast Glanbia, as the company posted a profit jump in its half year results.

Frutarom profits dip as raw material costs rise

Israel-based flavours, botanicals and speciality ingredients player Frutarom has reported lower profits in Q2, with raw material hikes cited as the principal cause.

Profits are up 6.1% at Kerry for H1, "despite significant raw material and input cost inflation"

Kerry delivers “solid” H1 with 6% profit hike to €214m

Irish dairy and ingredients group Kerry has turned in a”solid” first half of 2011 that saw it increase volumes, weather raw material price hikes, and see success in a “go-to-market”...

Splenda: 6-7% growth forecast

Analysts predict 6-7% sucralose growth for Tate & Lyle

UK analysts are forecasting 6-7% growth in sucralose for Tate & Lyle Splenda version of the sweetener which leads the segment globally.

Hans-Christian Ambjerg, president of DSM Food Specialties
Exclusive interview

Head of DSM Food Specialties tackles the big food ingredient issues

Hans-Christian Ambjerg, president of DSM Food Specialties, goes head to head with FoodNavigator.com on commodity prices, emerging markets and acquisition strategy.

Financials are on the rise at Naturex

Naturex doubles Q1 net profit as merger benefits arrive

French botanicals supplier Naturex has seen its 2011 Q1 net profit double from €2.4m to €4.8m on revenues of €64m, as benefits of its 2009 expansion kick in.

Disptaches from Vitafoods Europe 2011

DSM on Vitatene, Martek and its investment “shortlist”

DSM’s head of global marketing in human nutrition and health, Gareth Barker, explains why it has bought a carotenoid supplier (approval permitting), how the Martek acquisition is progressing, and why...

DuPont succeeds in Danisco bid

US chemical group DuPont has successfully completed its tender offer for Danisco, as 92.2 percent of outstanding shares in the Danish food ingredients firm were tendered by Friday’s deadline, DuPont...

The EC approves DuPont's offer, but do Danisco shareholders?

EU approves DuPont-Danisco offer – but it’s far from a done deal

The European Commission today approved DuPont’s €4.5bn offer for Danish probiotics, enzymes and ingredients giant Danisco but the deal remains in doubt as to date only 6% of Danisco shareholders...

DSM reports successful tender offer for Martek

Royal DSM’s acquisition of Martek Biosciences Corporation has moved a step closer to finalisation with the news that its tender offer to buy all of the company’s outstanding shares of...

DuPont extends Danisco offer deadline

DuPont has extended the tender offer period related to its acquisition of Danisco shares by more than a month to April 1, 2011, the company has said.

Analyst: DSM should be re-rated as a ‘nutrition plus’ company

Financial analyst Nomura says Dutch ingredients giant, Royal DSM should be classified as a “nutrition plus” company on the back of stable vitamin prices and margins.

A solid balance sheet will permit further acquisition activity, Raisio says

Raisio turns in healthy results and promises further acquisitions

Finnish ingredients and branded foods player Raisio – the owner of the stanol-cholesterol reduction brand Benecol, will continue seeking acquisitions, it announced in its 2010 financial statement that saw EBIT...

Danisco board accepts DuPont offer

Danisco’s executive board and members of its board of directors have accepted DuPont’s offer of DKK 665 per share, corresponding to 28,056 shares with a total value of DKK 18.7m,...

It would appear pharma giant Pfizer has gargantuan supplement ambitions as it buys Danish player, Ferrosan

Pfizer acquires Danish food supplements operation

Pfizer has acquired the consumer healthcare business of Danish firm Ferrosan for an undisclosed fee in what the pharma giant says, “is an excellent strategic fit that strengthens our presence...

Analysts: DuPont Danisco buy-out may end in fire sale

Analysts are saying Danisco could be carved up by its new owner DuPont, which they suggest is most interested in the Danish company’s enzymes for biofuels and that the food...